These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18606871)

  • 1. Paraquat exposure reduces nicotinic receptor-evoked dopamine release in monkey striatum.
    O'Leary KT; Parameswaran N; Johnston LC; McIntosh JM; Di Monte DA; Quik M
    J Pharmacol Exp Ther; 2008 Oct; 327(1):124-9. PubMed ID: 18606871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage.
    McCallum SE; Parameswaran N; Bordia T; McIntosh JM; Grady SR; Quik M
    Mol Pharmacol; 2005 Sep; 68(3):737-46. PubMed ID: 15933214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotinine selectively activates a subpopulation of alpha3/alpha6beta2 nicotinic receptors in monkey striatum.
    O'Leary K; Parameswaran N; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2008 May; 325(2):646-54. PubMed ID: 18305015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.
    Bordia T; Hrachova M; Chin M; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):327-34. PubMed ID: 22550286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to alpha6beta2* nAChRs.
    Khwaja M; McCormack A; McIntosh JM; Di Monte DA; Quik M
    J Neurochem; 2007 Jan; 100(1):180-90. PubMed ID: 17227438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prominent role of alpha3/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment.
    Perez XA; O'Leary KT; Parameswaran N; McIntosh JM; Quik M
    Mol Pharmacol; 2009 Apr; 75(4):938-46. PubMed ID: 19144785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial recovery of striatal nicotinic receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with chronic oral nicotine.
    Bordia T; Parameswaran N; Fan H; Langston JW; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2006 Oct; 319(1):285-92. PubMed ID: 16837557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
    Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
    J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of mesolimbic alpha 3/alpha 6 beta 2 and alpha 4 beta 2 nicotinic acetylcholine receptor sites and function after long-term oral nicotine to monkeys.
    McCallum SE; Parameswaran N; Bordia T; Fan H; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2006 Jul; 318(1):381-8. PubMed ID: 16622038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA.
    Quik M; Vailati S; Bordia T; Kulak JM; Fan H; McIntosh JM; Clementi F; Gotti C
    Mol Pharmacol; 2005 Jan; 67(1):32-41. PubMed ID: 15470079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function.
    Perez XA; Bordia T; McIntosh JM; Grady SR; Quik M
    Mol Pharmacol; 2008 Sep; 74(3):844-53. PubMed ID: 18583454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increases in alpha4* but not alpha3*/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment.
    McCallum SE; Parameswaran N; Bordia T; Fan H; Tyndale RF; Langston JW; McIntosh JM; Quik M
    J Neurochem; 2006 Feb; 96(4):1028-41. PubMed ID: 16412091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum.
    Exley R; McIntosh JM; Marks MJ; Maskos U; Cragg SJ
    J Neurosci; 2012 Feb; 32(7):2352-6. PubMed ID: 22396410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2* nAChRs in mouse, monkey, and Parkinson's disease striatum.
    Bordia T; Grady SR; McIntosh JM; Quik M
    Mol Pharmacol; 2007 Jul; 72(1):52-61. PubMed ID: 17409284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors.
    Drenan RM; Grady SR; Steele AD; McKinney S; Patzlaff NE; McIntosh JM; Marks MJ; Miwa JM; Lester HA
    J Neurosci; 2010 Jul; 30(29):9877-89. PubMed ID: 20660270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.
    Smith AM; Pivavarchyk M; Wooters TE; Zhang Z; Zheng G; McIntosh JM; Crooks PA; Bardo MT; Dwoskin LP
    Biochem Pharmacol; 2010 Aug; 80(3):402-9. PubMed ID: 20346923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice.
    Quik M; Sum JD; Whiteaker P; McCallum SE; Marks MJ; Musachio J; McIntosh JM; Collins AC; Grady SR
    Mol Pharmacol; 2003 May; 63(5):1169-79. PubMed ID: 12695545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors.
    van Hout M; Klein J; Ahring PK; Brown DT; Thaneshwaran S; Dos Santos AB; Jensen AA; Kohlmeier KA; Christophersen P; Dyhring T
    Biochem Pharmacol; 2020 Apr; 174():113788. PubMed ID: 31887290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination.
    Anderson DJ; Malysz J; Grønlien JH; El Kouhen R; Håkerud M; Wetterstrand C; Briggs CA; Gopalakrishnan M
    Biochem Pharmacol; 2009 Oct; 78(7):844-51. PubMed ID: 19555668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease.
    Perez XA; Bordia T; McIntosh JM; Quik M
    Mol Pharmacol; 2010 Nov; 78(5):971-80. PubMed ID: 20732972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.